tbuckley/cabot-search huggingface dataset:
IVIG-mediated protection against necrotizing pneumonia caused by MRSA
Authors: Binh An Diep, Vien T. M. Le, Cedric Badiou, Hoan N. Le, Marcos Gabriel Pinheiro, Au H. Duong, Xing Wang, Etyene Castro Dip, Fábio Aguiar-Alves, Li Basuino, Helene Marbach, Thuy T. Mai, Marie N. Sarda, Osamu Kajikawa, Gustavo Matute-Bello, Christine Tkaczyk, Jean-Philippe Rasigade, Bret R. Sellman, Henry F. Chambers, Gerard Lina
Journal: Science Translational Medicine (2016)

Human intravenous immunoglobulin contains specific antitoxin antibodies that protect against necrotizing pneumonia caused by MRSA in a rabbit model.
Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein in Low and High Grade B-Cell Non-Hodgkin Lymphomas and Differential Regulation of EZH2 Expression By p-ERK and MYC in High Grade B Cell Lymphomas
Authors: Xuejun Tian, Ali Shahsafaei, David M. Dorfman
Journal: Blood (2015)
Altered chemotherapeutic response of primary human breast cancer epithelial cells (HBCEC) and breast cancer cell lines
Authors: R. Hass, H. Lueck, R. von Wasielewski, H. Jin, A. Pich, H. Kuehnle, D. Grothuesmann, U. Hille, C. Bertram
Journal: Journal of Clinical Oncology (2007)

11506 Background: A novel technique to obtain individual primary cultures of human breast cancer biopsies was filed for patent (PCT/DE 2006/000608). The different individualized HBCEC (human breast cancer epithelial cell) cultures will be characterized and chemotherapeutic effects will be compared to established breast cancer cell lines. Methods: Primary HBCEC from 20 different breast cancer patients were characterized for epithelial cell and tumor markers by immunofluorescence and PCR. Following treatment with 1μM epirubicin for 1h up to 72h differences in protein expression patterns were compared to the similarly treated MCF-7 cell line by 2D gel electrophoresis. Differentially expressed protein spots were identified by mass spectrometry and confirmed by appropriate Western blot analysis. Results: Characterization of primary HBCEC revealed continuous mitosis and cell cycle progression for more than one year in culture with no significant contamination by fibroblasts or other cell types. Whereby HBCEC underwent cell death within 72h of epirubicin treatment analysis by 2D gel and subsequent protein identification by MALDI-TOF/TOF mass spectrometry exhibited a variety of differences compared to MCF-7 cells including HSP27 and prohibitin. Appropriate Western blots confirmed these differences and revealed altered expression levels for HSP27 and prohibitin in the course of epirubicin exposure in HBCEC and MCF-7 cells, respectively, suggesting altered signalling pathways in either primary breast cancer cells or the tumor cell line. Conclusions: Individualized primary HBCEC from various patients could provide a cellular platform beyond breast cancer cell lines, which eventually meet the requirements for an appropriate breast cancer testing system including the characterization of biomarkers and the identification of potential molecular targets. No significant financial relationships to disclose.
A Single Dose of Anti-MIR122 Oligonucleotide RG-101 Results in a less Activated Phenotype of NK Cells in Patients with Chronic Hepatitis C
Authors: F. Stelma, M.H. van der Ree, M.J. Sinnige, J. Marleen de Vree, S.B. Willemse, M. van der Valk, S. Neben, P. Grint, N.A. Kootstra, H.W. Reesink
Journal: Journal of Hepatology (2016)
Pro-Fibrogenic Host Protein Osteopontin Participates in HBV Replication and HBSAG Secretion
Authors: S. Phillips, J. Coombes, S. Mistry, M. Simonova, S. Pavlova, K. Katzarov, T. Hadzhiolova, T.A. Pereira, F.E. Pereira, R. Williams, W. Syn, S. Chokshi
Journal: Journal of Hepatology (2016)
Clinical and Functional Changes Associated with the Achievement of Sustained Response in HCV Genotype-1 Infected Liver Transplant Recipients: Does Sofosbuvir Differ from Peg-Interferon Therapy?
Authors: I. Lenci, M. Milana, F. Santopaolo, P. Rossi, S. Francioso, F. De Leonardis, D. Di Paolo, S. Cucchiarelli, C. Masetti, M. Angelico, L. Baiocchi
Journal: Journal of Hepatology (2016)
Sequencing Methods Developed for Hepatitis C Identifies a New Virus, Human Hepegivirus 1, in Patients with Advanced Cirrhosis
Authors: D.G. Bonsall, W.F. Gregory, C.L. Ip, S. Donfield, J. Iles, M.A. Ansari, P. Piazza, A. Trebes, J. Frater, O. Pybus, P. Goulder, P. Klenerman, A. Brown, R. Bowden, E.G. Gomperts, E. Barnes, A. Kapoor, C. Sharp, P. Simmonds
Journal: Journal of Hepatology (2016)
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation
Authors: Harvey Pass, Dorothy Giroux, Catherine Kennedy, Enrico Ruffini, Ayten K. Cangir, David Rice, Hisao Asamura, David Waller, John Edwards, Walter Weder, Hans Hoffmann, Jan P. van Meerbeeck, Anna Nowak, Valerie W. Rusch, Peter Goldstraw, Ramón Rami-Porta, Hisao Asamura, David Ball, David Beer, Ricardo Beyruti, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Ernst Erich Eberhardt, John Edwards, Françoise Galateau-Sallé, Dorothy Giroux, Fergus Gleeson, Patti Groome, James Huang, Catherine Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna Nowak, Michael Peake, Thomas Rice, Kenneth Rosenzweig, Enrico Ruffini, Valerie Rusch, Nagahiro Saijo, Paul Van Schil, Jean-Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William Travis, Ming S. Tsao, Andrew Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi-Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp Kernstine, Hedy Kindler, Lee Krug, Kristiaan Nackaerts, Harvey Pass, David Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene Blackstone, H. Asamura, H. Batirel, A. Bille, U. Pastorino, S. Call, A. Cangir, S. Cedres, J. Friedberg, F. Galateau-Salle, None Hasagawa, K. Kernstine, H. Kindler, B. McCaughan, T. Nakano, A. Nowak, C. Atinkaya Ozturk, H. Pass, M. de Perrot, F. Rea, D. Rice, R. Rintoul, E. Ruffini, V. Rusch, L. Spaggiari, D. Galetta, K. Syrigos, C. Thomas, J. van Meerbeeck, J. Vansteenkiste, W. Weder, I. Opitz, M. Yoshimura
Journal: Journal of Thoracic Oncology (2016)
Cirrhotic Patients with TLR-9 rs187084 Polymorphism do not Increase Serum Levels of Cytokines, Dopamine and Noradrenaline in Response to Bacterial DNA
Authors: P. Piñero, P. Zapater, O. Juanola, P. Giménez, E. Caparrós, J.M. González-Navajas, R. Francés
Journal: Journal of Hepatology (2016)
Overcoming barriers to hospice care for children with cancer: Promoting active participation of the oncology team.
Authors: Karen S. Fernandez, Diane Rogers, Leigh M. Look, Reuben Antony
Journal: Journal of Clinical Oncology (2015)

131 Background: The concept of pediatric hospice care is a natural progression of the hospice philosophy as it has been applied to adults, although, there are unique challenges presented by children. At our institution hospice service for children are offered by the adult team. We evaluated the number of children with cancer eligible for hospice between July 2009 and May 2015 and also explored the barriers that prevented hospice enrollment and the experiences of families, and hospice staff. Methods: Retrospective Review, Programmatic Initiative. Results: Thirty-two children diagnosed with cancer died in a 6 year period. Diagnosis breakdown was: Solid tumors 17/32 (53%), brain tumors 8/32 (25%), leukemia/lymphoma 6/32 (19%), 1 rare hematology condition. Twenty-one patients (65%) were 0 – 9.99 years and 11(35%) between 10 – 19.99 years. Fifteen patients (47%) were enrolled in hospice and all died at home except one. 18/32 (56%) children died in the hospital, of those 10/18 (55%) their parents chose the hospital as the site for their children passing, 6/18 (33%) died from an unexpected acute episode that resulted in death, and 2/18 (11%) patients had an acute episode that lead to un-planned patient hospitalization. The identified barriers to establishing and delivering hospice care were: a) family unwillingness to work with the hospice team b) family desire to have the patient die in the hospital c) hospice services not available in the patient’s residential area and, d) low level of comfort in the care of young children on the part of the hospice staff. Families expressed mixed feelings regarding hospice services. Conclusions: Hospice services for children with cancer are underutilized. There are family, institutional and community barriers to hospice enrolment for children with cancer. The great majority of patients still die in the hospital. We propose to improve our regional pediatric hospice service by strengthening collaboration between pediatric oncology, palliative care and hospice to better serve children with cancer at the end of life with a programmatic initiative involving the oncology team. We aim to evaluate the impact of this initiative on families, hospice staff and the oncology team.
Integration-defective lentiviral vectors for hemophilia: a safer platform for immune tolerance inducation and reduced genotoxicity
Authors: Janka Matrai, A Cantore, C Bartholomae, A Annoni, Abel Acosta Sanchez, Ermira Samara, L De Waele, L Ma, TC Nichols, C von Kalle, MG Roncarolo, Marinee Chuah, M Schmidt, Thierry Vandendriessche, L Naldini
Journal: Molecular Therapy (2010)
Surveillance of Hepatocellular Carcinoma by Magnetic Resonance Imaging With Liver-Specific Contrast
Authors: Tung-Hung Su, Jia-Horng Kao
Journal: JAMA Oncology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Non-Tumoral Portalvein Thrombosis and End-Stage Liver Disease in Patients with Cirrhosis: A Longitudinal Retrospective Cohort
Authors: J. Roux, P. Sultanik, S. Bouam, A. Vallet-Pichard, H. Fontaine, M. Corouge, V. Mallet, S. Pol, P. Sogni
Journal: Journal of Hepatology (2016)
High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA.
Authors: Adrian Wiestner, Michael Chiorazzi, Raymond Lai, Andreas Rosenwald, H. Konrad Muller-Hermelink, German Ott, Wing C. Chan, Timothy C. Greiner, Dennis D. Weisenburger, Julie Vose, James O. Armitage, Randy D. Gascoyne, Joseph M. Connors, Elias Campo, Emilio Montserrat, Francesc Bosch, Erlend B. Smeland, Stein Kvaloy, Harald Holte, Jan Delabie, Richard I. Fisher, Thomas M. Grogan, Thomas P. Miller, Wyndham H. Wilson, Elaine S. Jaffe, Louis M. Staudt
Journal: Blood (2004)
Aurora B kinase and malignant mesothelioma.
Authors: P. Betta, T. Bensi, N. F. Trincheri, E. Arnolfo, R. Libener, M. Botta, E. Piccolini, G. Bottero, F. Grosso, S. Orecchia
Journal: Journal of Clinical Oncology (2010)

e21021 Background: Malignant mesothelioma (MM) is an aggressive neoplasm of the serosal cavities, resistant to conventional treatment, for which new therapeutic targets are being actively sought. Aurora kinases (AURKA, AURKB and AURKC) are a family of serine/threonine kinases involved in multiple facets of mitosis. These are aberrantly up-regulated in several cancers, suggesting that they might play a role in tumorigenesis and thus serve as potential targets for anticancer drugs. Genomic microarray analysis has related AURKA and AURKB with a more aggressive clinical course and a shorter survival in MM. AZD1152-hydroxyquinazoline-pyrazol-anilide (AZD1152-HQPA) is a highly potent, selective AURKB inhibitor which reduces cell viability and induces apoptosis. This study evaluates the protein expression of AURKB in MM cell lines (n = 4) and MM tissue specimens (n = 56) and examines the effects of AZD1152-HQPA on MM cell lines. Methods: We did immunohistochemistry using a monoclonal AURKB antibody (Cell Signaling Technology, Beverly MA; 1:50 dilution). In vitro cell survival and apoptosis were assessed by MTT and TUNEL assays, respectively. Results: There was a ubiquitous protein expression varying in intensity (from moderate to intense) and localization (nuclear or cytoplasmatic) and irrespective of the MM histological subtype. Furthermore 4 MM cell lines, established from pleural fluids of MM patients, were incubated with varying concentrations of AZD1152-HQPA and subsequent MTT and TUNEL assays showed a reduction in cell viability with ensuing apoptotic cell death. An immunoblot analysis on the same cell lines treated for 24h with EC50 of AZD1152-HQPA showed a nondecisive AURKB modulation of expression, shifting from down-regulation in 2 cell lines to up-regulation in the other 2. Conclusions: The results suggest that AZD1152-HQPA may be of potential therapeutic value in inhibiting the growth of MM, and qualify further investigation in AURKB pathway. The study was financially supported by Regione Piemonte-Progetti Ricerca Sanitaria Finalizzata anno 2008 bis and LILT-Alessandria. No significant financial relationships to disclose.
Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells
Authors: Elina Timosenko, Hemza Ghadbane, Jonathan D. Silk, Dawn Shepherd, Uzi Gileadi, Lauren J. Howson, Robert Laynes, Qi Zhao, Robert L. Strausberg, Lars R. Olsen, Stephen Taylor, Francesca M. Buffa, Richard Boyd, Vincenzo Cerundolo
Journal: Cancer Research (2016)

Abstract Tryptophan degradation is an immune escape strategy shared by many tumors. However, cancer cells' compensatory mechanisms remain unclear. We demonstrate here that a shortage of tryptophan caused by expression of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) resulted in ATF4-dependent upregulation of several amino acid transporters, including SLC1A5 and its truncated isoforms, which in turn enhanced tryptophan and glutamine uptake. Importantly, SLC1A5 failed to be upregulated in resting human T cells kept under low tryptophan conditions but was enhanced upon cognate antigen T-cell receptor engagement. Our results highlight key differences in the ability of tumor and T cells to adapt to tryptophan starvation and provide important insights into the poor prognosis of tumors coexpressing IDO and SLC1A5. Cancer Res; 76(21); 6193–204. ©2016 AACR.
Both low circulating insulin-like growth factor-1 and high-density lipoprotein cholesterol are associated with hair loss in middle-aged women
Authors: R. Noordam, D.A. Gunn, K. van Drielen, G. Westgate, P.E. Slagboom, A.J.M. de Craen, D. van Heemst
Journal: British Journal of Dermatology (2016)

Multiple biomarkers have been associated with hair loss in women, but studies have shown inconsistent results.We investigated the associations between markers of cardiovascular disease risk (e.g. serum lipid levels and hypertension) and ageing [e.g. 25-hydroxyvitamin D and insulin-like growth factor (IGF)] with hair loss in a population of middle-aged women.In a random subgroup of 323 middle-aged women (mean age 61·5 years) from the Leiden Longevity Study, hair loss was graded by three assessors using the Sinclair scale; women with a mean score > 1·5 were classified as cases with hair loss.Every 1 SD increase in high-density lipoprotein (HDL) cholesterol was associated with a 0·65-times lower risk [95% confidence interval (CI) 0·46-0·91] of hair loss. For IGF-1 the risk was 0·68 times lower (95% CI 0·48-0·97) per 1 SD increase, independently of the other studied variables. Women with both IGF-1 and HDL cholesterol levels below the medians of the study population had a 3·47-times higher risk (95% CI 1·30-9·25) of having hair loss.Low HDL cholesterol and IGF-1 were associated with a higher risk of hair loss in women. However, further studies are required to infer causal relationships.
Carboplatin (Cb) clearance (Cl) in elderly and young patients with advanced non-small cell lung cancer (ANSCLC): An exploratory analysis of the Calvert’s formula
Authors: M. Merino, I. Maestu, M. Tallón, D. Almenar, V. G. Casabó, J. Muñoz, N. V. Jiménez
Journal: Journal of Clinical Oncology (2007)

18047 Background: It seems that elderly lung cancer patients (p) respond better to combination chemotherapy than to single-agent therapy. Application of pharmacokinetic (pk) modelling to the routine therapeutic drug monitoring in elderly p help to individualize the dosage of anticancer drugs. The aim of this study was to explore the Calvert′s formula usefulness for calculating the Cb dose in elderly p by means of the predicted AUC/actual AUC ratio. Creatinine (Cr) Cl was calculated by Cockdroft-Gault equation. Methods: Between December 2005 and September 2006, 20 chemonaive ANSCLC p were included in two groups: 10 adults p ≤ 65 years and 10 aged p ≥ 75 years. Treatment consisted in Cb day 1 and gemcitabine 1250 mg/m 2 days 1 and 8 every 21 days. Cb dose was calculated for a foreseen AUC = 5 in young adults and AUC = 4 in aged p. Three blood samples were collected at 1–2 hours(h), 3–5 h, 12–24 h postinfusion. Total and ultrafiltrated Cb was determined using a flameless atomic absortion spectrometer. For pk analysis non lineal effects models implemented in NONMEM program were used. Individual pk parameters were calculated and predictors in the structural model were analized. Results: Table 1 shows mean and variation coefficient of some biometric characteristics. Pk parameters analysis: Cl AUC5 p = 137 mL/min; Cl factor (parameter for measuring Cl changes according to age) = 0.44; Cl AUC4 p = 59.7 mL/min. Cb Cl in elderly p was 43.55% with respect to younger p. In younger p estimated Cb Cl was 5.69% higher than Cb Cl calculated using the Calvert equation. In elderly p, the opposite effect was achieved, estimated Cb Cl was 26.85% lower than Cb Cl calculated Conclusions: The Cb Cl calculation by means of Calvert formula showed underestimation of the dose in younger p and upperestimation of the dose in elderly p. It is necessary to investigate the covariates which contribute to take away the strength of the Calvert equation, which could to affect the efficacy and toxicity of Cb. [Table: see text] No significant financial relationships to disclose.
A Microrna-Based Diagnostic Tool to Predict Advanced Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B and C
Authors: K. Appourchaux, E. Estrabaud, M. Resche-Rigon, M. Lapalus, M. Martinot-Peignoux, S. Dokmak, X. Treton, N. Boyer, M. Vidaud, P. Bedossa, P. Marcellin, T. Asselah
Journal: Journal of Hepatology (2016)
IL-7 Induced Traf1 Up-Regulation Restores HCV-Specific CD8 T Cell Reactivity in Mid-Lasting HCV Infection Featured by Presence of Directly Ex-Vivo Detectable Pentamer Binding Cells
Authors: E. Moreno-Cubero, D. Subirá, E.S. de Villalobos, J. Míquel, R. Borobia, A. Lázaro, A.G. Pretorius, J.R. Larrubia
Journal: Journal of Hepatology (2016)
The Pil3 pilus of<i>Streptococcus gallolyticus</i>binds to intestinal mucins and to fibrinogen
Authors: Mariana Martins, Constance Porrini, Laurence du Merle, Camille Danne, Catherine Robbe-Masselot, Patrick Trieu-Cuot, Shaynoor Dramsi
Journal: Gut Microbes (2016)

Streptococcus gallolyticus is a commensal bacterium responsible for infectious endocarditis in the elderly, which has frequently been associated with colonic carcinoma. Whether this species is a cause or a consequence of colorectal cancer remains unknown. We recently demonstrated that S. gallolyticus Pil3 pilus is required for adhesion to colonic mucus and for colonization of mouse distal colon. We show here that Pil3 pilus binds equally well to human colonic mucins derived from HT29-MTX cells and to human stomach mucins from healthy donors. In addition, we have found that Pil3 also binds to human fibrinogen, which expands the repertoire of Pil3 host ligands.
Multi-Parametric Magnetic Resonance Imaging of the Spleen: An Accurate and Non-Invasive Biomarker of Portal Pressure
Authors: M. Pavlides, C. Levick, J. Phillips-Hughes, J. Collier, R. Banerjee, L.M. Wang, J. Cobbold, M. Robson, S. Neubauer, E. Barnes
Journal: Journal of Hepatology (2016)
Remote haemodynamic‐guided care for patients with chronic heart failure: a meta‐analysis of completed trials
Authors: Philip B. Adamson, Greg Ginn, Stefan D. Anker, Robert C. Bourge, William T. Abraham
Journal: European Journal of Heart Failure (2016)

Abstract Aims Haemodynamic‐guided heart failure ( HF ) management using directly measured cardiac filling pressures in symptomatic patients is now recommended in the European Society of Cardiology ( ESC ) Heart Failure Guidelines [Class IIb (B)]. This meta‐analysis evaluates all data from completed clinical trials evaluating this approach in patients with HF . Methods and results All trials evaluating the impact of HF management based on haemodynamic monitoring using implantable devices were reviewed using standard search engine methods. PRISMA methods were used to evaluate and screen publications that included an evaluation of an effect on HF hospitalizations. All publications meeting the inclusion criteria were included, and the outcomes data were evaluated using standard meta‐analysis methodology. Of 317 publications initially identified, five trials involving 1296 patients with chronic HF met the criteria used in this meta‐analysis. Studies included prospective controlled designs, as well as observational studies with historical control. Heterogeneity testing failed to demonstrate instability of analysis due to differences between trials. When compiled, outcomes from these trials favoured remote haemodynamic monitoring with a significant 38% reduction in HF hospitalizations (hazard ratio 0.62, 95% confidence interval 0.50–0.78, P &lt; 0.001). Conclusions Haemodynamic‐guided HF management using permanently implanted sensors and frequent filling pressure evaluation is superior to traditional clinical management strategies in reducing long‐term HF hospitalization risk in symptomatic patients.
Comparison of Thromboembolic Event Rates in Randomized Controlled Trials and Observational Studies of Recombinant Factor VIIa for Off-Label Indications.
Authors: Veronica Yank, Aaron C. Logan, C. Vaughan Tuohy, Dena M. Bravata, Kristan Staudenmayer, Robin Eisenhut, Vandana Sundaram, Donal McMahon, Kathryn M. McDonald, Douglas Owens, Randall S. Stafford
Journal: Blood (2009)
Contrasting Effects of Enhanced Sirt1 Activity in Normal and BCR-ABL1-Depedent Haematopoiesis
Authors: Ming Hu, Jamshid S Khorashad, Aristeidis Chaidos, Georgios Nteliopoulos, Mattaka Khongkow, Irene Roberts, John Goldman, Alistair Reid, Eric W-.F. Lam, Jane Apperley, Anastasios Karadimitris
Journal: Blood (2012)
Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: insights from SYMPHONY, a large international trial
Authors: DK McGuire, LK Newby, MV Bhapkar, DJ Moliterno, EM Ohman, C Dougherty, RA Harrington, HD White, Frans Van de Werf, RM Califf, EJ Topol
Journal: Journal of the American College of Cardiology (2001)